UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000013436
Receipt number R000015633
Scientific Title Neuroimaging study in autism spectrum disorder
Date of disclosure of the study information 2014/04/01
Last modified on 2016/11/12 09:04:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Neuroimaging study in autism spectrum disorder

Acronym

Neuroimaging study in ASD

Scientific Title

Neuroimaging study in autism spectrum disorder

Scientific Title:Acronym

Neuroimaging study in ASD

Region

Japan


Condition

Condition

Individuals with autism spectrum disorder

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Autism is a neurobiological condition with a strong genetic component characterized by impairments in social interaction and communication as well as restricted, repetitive, and stereotyped patterns of behavior, interests, and activities. Family studies
have indicated that concordance rates for autism are 2% to 6% for siblings and dizygotic twins and approximately 60% for monozygotic twins. Still, most siblings of probands with autism do not have any symptoms of autism despite sharing, on average, 50% of their genes and many environmental influences with their siblings with autism. Furthermore, previous studies have suggested that individuals with autism share some aspects of brain structure and function as well as behavioral and immune profiles with their siblings who do not have autism. Therefore, we sought to investigate the similarity and difference of brain anatomy and function among individuals with high-functioning autism spectrum disorder and their siblings to reveal the neurobiological and genetic substrates in high-functioning autism spectrum disorder.

Basic objectives2

Others

Basic objectives -Others

To detect the neurobiological substrates in autism spectrum disorder.

Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

1. Voxel-based Morphometry (VBM)
2. Diffusion Tensor Imaging (DTI)
3. Free Surfer
4. Functional MRI (fMRI)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Individuals with autism spectrum disorder

Interventions/Control_2

Siblings of autism spectrum disorder

Interventions/Control_3

Normal controls

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

65 years-old >

Gender

Male and Female

Key inclusion criteria

Participants diagnosed as an autism spectrum disorder recruited from Showa university karasuyama hospital, their same-sex unaffected siblings, and healthy controls

Key exclusion criteria

Participants have any other neurological or psychiatric disorders

Target sample size

90


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Osamu Takashio

Organization

Showa University School of Medicine

Division name

Department of Psychiatry

Zip code


Address

6-11-11 Kita-Karasuyama, Setagaya-Ku, Tokyo, Japan

TEL

03-3300-5231

Email

takashio@med.showa-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Bun Yamagata

Organization

Keio University School of Medicine

Division name

Department of Neuropsychiatry

Zip code


Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-5363-3829

Homepage URL


Email

yamagata@a6.keio.jp


Sponsor or person

Institute

Showa University School of Medicine, Department of Psychiatry

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid forYoung Scientists (B)

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

昭和大学附属烏山病院(東京都)


Other administrative information

Date of disclosure of the study information

2014 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2014 Year 02 Month 24 Day

Date of IRB


Anticipated trial start date

2014 Year 05 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2014 Year 03 Month 17 Day

Last modified on

2016 Year 11 Month 12 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000015633


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name